Antoine Awad
Plus aucun poste en cours
Fortune : 52 820 $ au 31/05/2024
Profil
Antoine Awad served as the Chief Executive Officer at Synlogic, Inc. from 2024.
Prior to that, he worked as the Senior Vice President of Manufacturing & Operations at Abpro Corp.
He also held the position of Head of Process Sciences & Manufacturing at Merrimack Pharmaceuticals, Inc. and was a Senior Vice President at L.E.A.F.
Pharmaceuticals LLC.
Mr. Awad completed his undergraduate degree at Boston University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SYNLOGIC INC
0,29% | 02/04/2024 | 33 859 ( 0,29% ) | 52 820 $ | 31/05/2024 |
Anciens postes connus de Antoine Awad
| Sociétés | Poste | Fin |
|---|---|---|
| SYNLOGIC, INC. | Directeur Général | 30/05/2024 |
| MERRIMACK PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
L.E.A.F. Pharmaceuticals LLC
 L.E.A.F. Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology L.E.A.F. Pharmaceuticals LLC engages in a pharmaceuticals company. It develops and commercializes therapies for cancer, autoimmune, and infectious diseases. The company was founded by Clet Niyikiza and is headquartered in Woburn, MA. | Corporate Officer/Principal | - |
| ABPRO CORPORATION | Directeur des opérations | - |
Formation de Antoine Awad
| Boston University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SYNLOGIC, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Abpro Corp.
 Abpro Corp. BiotechnologyHealth Technology Abpro Corp. operates as a biotechnology company which develops antibody therapeutics for severe and life threatening diseases. It focusses on novel antibody constructs for immuno-oncology, ophthalmology, and autoimmunity. The company was founded by Ian Chan and Eugene Y. Chan in 2007 and is headquartered in Woburn, MA. | Health Technology |
L.E.A.F. Pharmaceuticals LLC
L.E.A.F. Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology L.E.A.F. Pharmaceuticals LLC engages in a pharmaceuticals company. It develops and commercializes therapies for cancer, autoimmune, and infectious diseases. The company was founded by Clet Niyikiza and is headquartered in Woburn, MA. | Health Technology |
Merrimack Pharmaceuticals, Inc.
 Merrimack Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Merrimack Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. engages in discovering, developing, and commercializing medicines consisting of novel therapeutics paired with diagnostics for the treatment of cancer. Its pipeline includes MM-131, MM-141, and MM-310. The company was founded by Anthony J. Sinskey, Gavin MacBeath, and Ulrik B. Nielsen in 1993 and is headquartered in Cambridge, MA. | Health Technology |
